Skip to main content
OpenTrials
Completed

NCT Number: NCT03379519

Protocol of Multi-domain Attention Training

This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This double-blind randomized controlled study has a 2-arm parallel group design. All subjects will be randomized by the block randomization, into intervention group (Multi-domain Attention Training, MAT), or active control group (Passive information activities, PIA). Training sessions of the MAT group are 45 minutes/day, 3 days/week, for 12 weeks (36 sessions each). The training of PIA group is the same as MAT group. The investigators constructed a rigorous MAT program adhering to the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines. The investigators expect to determine the improvement in attention function of older adults with mild cognitive impairment after using the MAT program.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must endorse at least two items from a list of frequent subjective memory complaints by patient and/or an informant
  • Objective memory impairment on neuropsychological tests of memory 1.5 SD or more below age/education norms
  • Clinical neurologic examination by the Mini-Mental State Examination (MMSE) score of 24 or higher
  • No impairment in personal activities of daily living (P-ADL) as determined by clinical interview with participant and family

Exclusion criteria

  • The clinical diagnosis of dementia was based on the DSM-IV-TR
  • Active in another cognitive or memory-related training in the past year
  • Comorbid medical conditions that would predispose them to imminent functional decline or cognitive impairment
  • A diagnosis of major neurological or psychiatric illness history and/or behavioral problems that would sufficiently impair performance to make participation impossible
  • Severe losses in vision, hearing, or communicative ability

Treatment and study plan

Multi-domain Attention Training (MAT)

Behavioral

The training content emphasis three concept of attention include: intensity of attention, executive attention, and spatial orienting attention.

Other names: Attention training

Passive information activities (PIA)

Behavioral

The active control group (Passive information activities) training content included reading online e-books and playing online games.

Other names: Active control group

Primary outcomes

  1. Change in attention as measured by the Digit Span Task (DS).

    Time frame: Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.

    The primary outcome indicators is executive attention assessed by the Digit Span Task (DS).

Secondary outcomes

  1. Change in attention as measured by the Trail Making Test (TMT).

    Time frame: Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.

    The secondary outcome indicator is spatial orienting attention evaluated by the Trail Making Test.

Sponsors and collaborators

Lead sponsor

Ministry of Science and Technology, Taiwan

Other Gov

Registry information

Official study title

The Development and Evaluation of Multi-domain Attention Training for Older Adults With Mild Cognitive Impairment

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Dec 20, 2017
Registry last updated
Feb 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.